SEARCH
FDA Issues Recall Notice of Common Blood Pressure Medication Citing Cancer Risk
Veuer
2022-12-27
Views
39
Description
Share / Embed
Download This Video
Report
This is the second blood pressure medication recall for the same issue this year. Veuer’s Tony Spitz has the details.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x8gofb4" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:35
FDA Reclassifies Costco Egg Recall to Highest Risk Level, Citing Severe Health Concerns
05:00
FDA: Yet Another Blood Pressure Medication Recall Due To Cancer Concerns - 1breakingnews.com
00:51
FDA Announces Recall of Blood Pressure Medications Over High Levels of Possible Carcinogenic—Here's What to Do
01:30
Pfizer Issues Recall of Blood Pressure Medication
02:34
FDA panel recommends pulling Makena, citing ineffectiveness of controversial preterm birth dru - 1br
01:02
US: FDA authorises e-cigarette in a first, citing benefit for smokers
00:45
Starbucks Recalls Bodum Recycled Coffee Presses Citing 'Laceration Hazard'
01:24
Takata Expands Recall Again, Citing New Airbag Hazard
00:58
Nicaraguan media outlets close, citing gov't pressure
01:07
Naomi Osaka withdraws from French Open, citing media pressures and mental health
01:24
China aims for modest 5.5% GDP growth in 2022, citing economic pressures
00:42
Top Democrats, Schumer and Pelosi Pressure Biden to Drop Out of Reelection Campaign, Citing Doubts on His Ability to Beat Trump